Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer
CompletedOBSERVATIONAL
Enrollment
716
Participants
Timeline
Start Date
April 1, 2012
Primary Completion Date
May 31, 2023
Study Completion Date
May 31, 2023
Conditions
Breast CancerSentinel Lymph Node
Interventions
PROCEDURE
Test cohort
Trial Locations (1)
350001
Chuan Wang, Fuzhou
All Listed Sponsors
lead
Fujian Medical University Union Hospital
OTHER
NCT06149377 - Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer | Biotech Hunter | Biotech Hunter